When controlling for prior COVID-19, the association of frailty with vaccine-specific AIM+CD8+ and AIM+CD4+ T cells remained non-significant (p = 0.17 and p = 0.12, respectively) [Fig. 4A & B]. This evidence concerns the gene CD4 and COVID-19.